SCHEMBL6283657

SCHEMBL6283657

CCOC(=O)c1cn(-c2ccccn2)c2oc(CN3CCOCC3)cc2c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
TSHR P16473 2/20 0.44
PIK3CA P42336 1/20 0.43
HSD17B10 Q99714 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
MAPT P10636 2/20 0.41
TP53 P04637 3/20 0.41
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
USP2 O75604 1/20 0.40
KCNH2 Q12809 1/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6283840 0.87 ALDH1A1 (0.61) ALDH1A1TSHRHSD17B10NPSR1MAPT
SCHEMBL6282326 0.80 ALDH1A1 (0.56) ALDH1A1TSHRHSD17B10NPSR1MAPT
SCHEMBL6278248 0.80 ALDH1A1 (0.56) ALDH1A1TSHRHSD17B10NPSR1MAPT
SCHEMBL6282380 0.79 KCNH2 (0.54) ALDH1A1KCNH2KMT2AMEN1
SCHEMBL6287389 0.78 ALDH1A1 (0.57) ALDH1A1TSHRHSD17B10NPSR1MAPT
SCHEMBL6277350 0.78 ALDH1A1 (0.53) ALDH1A1TSHRHSD17B10NPSR1MAPT
SCHEMBL6283853 0.77 ALDH1A1 (0.52) ALDH1A1TSHRHSD17B10NPSR1MAPT
SCHEMBL6281585 0.77 HPGD (0.47) ALDH1A1TSHRNPSR1MAPTTP53
SCHEMBL6285075 0.75 ALDH1A1 (0.50) ALDH1A1TSHRHSD17B10NPSR1MAPT
SCHEMBL7175985 0.73 ELANE (0.50) ALDH1A1NPSR1MAPTTP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6878705-B2 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents PFIZER (US) 2005-04-12 US disclosed
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY 2004-12-23 US disclosed
EP-1465895-A2 4-OXO-4,7-DIHYDROFURO(2,3-B)PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2004-10-13 EP disclosed
WO-2003059911-A2 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS IL4, ZC3HAV1, IRF3 ALDH1A1 1363/4885TSHR 3637/4885PIK3CA 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.